Ed Horn1, Judith Jacobi. 1. The Johns Hopkins Hospital (EH), Baltimore, MD, USA.
Abstract
OBJECTIVE: To review the history, training requirements, contributions to patient care outcomes, and workforce issues of critical care pharmacists. DATA SOURCE AND SELECTION: Literature obtained through Medline search with manual cross-referencing. DATA EXTRACTION AND SYNTHESIS: Original and selected review articles and guideline documents were reviewed for references to critical care pharmacists and their role on the multiprofessional critical care team. CONCLUSIONS: Critical care pharmacists are recognized as essential members of the critical care team as a result of contributions to medication safety, improved patient outcomes, and reduced drug costs and as a source of drug information and provider of education. A growing number of pharmacists practice in critical care. Additional opportunities exist and can be met if an adequate supply of trained specialists can be developed.
OBJECTIVE: To review the history, training requirements, contributions to patient care outcomes, and workforce issues of critical care pharmacists. DATA SOURCE AND SELECTION: Literature obtained through Medline search with manual cross-referencing. DATA EXTRACTION AND SYNTHESIS: Original and selected review articles and guideline documents were reviewed for references to critical care pharmacists and their role on the multiprofessional critical care team. CONCLUSIONS: Critical care pharmacists are recognized as essential members of the critical care team as a result of contributions to medication safety, improved patient outcomes, and reduced drug costs and as a source of drug information and provider of education. A growing number of pharmacists practice in critical care. Additional opportunities exist and can be met if an adequate supply of trained specialists can be developed.
Authors: B E Bosma; N G M Hunfeld; E Roobol-Meuwese; T Dijkstra; S M Coenradie; A Blenke; W Bult; P H G J Melief; M Perenboom-Van Dixhoorn; P M L A van den Bemt Journal: Int J Clin Pharm Date: 2020-08-19
Authors: Daniel G Ford; Amy L Seybert; Pamela L Smithburger; Lawrence R Kobulinsky; Joseph T Samosky; Sandra L Kane-Gill Journal: Intensive Care Med Date: 2010-03-19 Impact factor: 17.440